MMEN — Medmen Enterprises Share Price
0.000.00%
Last trade - 00:00Consumer CyclicalsSpeculativeMicro Cap
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -50.52% | ||
| Operating Margin | -37.65% | ||
Financial Summary
| Year End 25th Jun | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 39.78 | 119.92 | 155.29 | 132.25 | 140.81 | n/a | n/a | 839.28% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MedMen Enterprises Inc. is a retail cannabis company with an operational footprint in California, Nevada, Illinois, Massachusetts, and New York. The Company offers a robust selection of high-quality products, including MedMen-owned brands MedMen Red, Moss and LuxLyte, through its premium retail stores, proprietary delivery service, as well as curbside and instore pickup. MedMen Buds, a loyalty program, provides access to promotions, product drops and content. It produces and curates the consumer product assortment for retail operations in its local communities with services and engaging in-store experience, combined with reward, delivery, and e-commerce programs. It also offers buds rewards, where buds members earn points with every purchase, plus exclusive access to drops and deals. The Company also provides gift cards.
Directors
- Michael Serruya CHM (57)
- Reece Fulgham CFO
- Tracy McCourt CEX
- Rozlyn Lipsey COO (51)
- Tyson Rossi OTH
- David Hsu DRC (39)
- Edward Record DRC (53)
- Melvin Elias IND
- Cameron Smith IND
- Last Annual
- June 25th, 2022
- Last Interim
- March 25th, 2023
- Incorporated
- May 21st, 1987
- Public Since
- January 19th, 1988
- No. of Employees
- 702
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 1,441,683,450
- Address
- 8740 S. SEPULVEDA BOULEVARD, SUITE 105, LOS ANGELES, 90045
- Web
- https://medmen.com/
- Phone
- +1 4243302082
- Auditors
- MNP LLP
Upcoming Events for MMEN
Q3 2024 Medmen Enterprises Inc Earnings Release
Q4 2023 Medmen Enterprises Inc Earnings Release
Similar to MMEN
Ambari Brands
Canadian Securities Exchange
Delota
Canadian Securities Exchange
Optimi Health
Canadian Securities Exchange
Peekaboo Beans
Canadian Securities Exchange
Psyched Wellness
Canadian Securities Exchange
FAQ
What is the Medmen Enterprises share price?
As of Today at 19:14 UTC, shares in Medmen Enterprises are trading at CA$0.02. This share price information is delayed by 15 minutes.
How has the Medmen Enterprises share price performed this year?
Shares in Medmen Enterprises last closed at CA$0.02 and the price had moved by -40% over the past 365 days. In terms of relative price strength the Medmen Enterprises share price has underperformed the Toronto Stock Exchange 300 Composite Index by -45.08% over the past year.
What are the analyst and broker recommendations for Medmen Enterprises?
The overall consensus recommendation for Medmen Enterprises is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Medmen Enterprises dividend yield?
Medmen Enterprises does not currently pay a dividend.
Does Medmen Enterprises pay a dividend?
Medmen Enterprises does not currently pay a dividend.
When does Medmen Enterprises next pay dividends?
Medmen Enterprises does not currently pay a dividend.
How do I buy Medmen Enterprises shares?
To buy shares in Medmen Enterprises you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Medmen Enterprises?
As of the previous close price of CA$0.02, shares in Medmen Enterprises had a market capitalisation of .
Where are Medmen Enterprises shares listed?
Here are the trading details for Medmen Enterprises:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: MMEN
What kind of share is Medmen Enterprises?
Based on an overall assessment of its quality, value and momentum Medmen Enterprises is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Medmen Enterprises share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Medmen Enterprises share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medmen Enterprises. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -55.83%.
As of the last closing price of CA$0.02, shares in Medmen Enterprises were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Medmen Enterprises PE Ratio?
The Medmen Enterprises PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Medmen Enterprises?
Medmen Enterprises' management team is headed by:
- Michael Serruya - CHM
- Reece Fulgham - CFO
- Tracy McCourt - CEX
- Rozlyn Lipsey - COO
- Tyson Rossi - OTH
- David Hsu - DRC
- Edward Record - DRC
- Melvin Elias - IND
- Cameron Smith - IND